IM Cannabis IMCC

NASDAQ IMCC
$0.11 +0.00 (+1.05%)
At close: Aug 19, 2026 · 4:00 PM UTC
Financial Ratios
Market Cap506,828.79
P/E-0.04
P/S0.02
Div. Yield0.00
ROIC (Qtr)-0.01
Total Debt (Qtr)8.72 Mn
Revenue Growth (1y) (Qtr)-40.12
Add ratio to table…

About

IM Cannabis Corp. is an international cannabis company focused on the importation, distribution and sale of medical cannabis products to medical patients in Israel and Germany. The company operates medical cannabis retail pharmacies, online platforms, distribution centers and logistical hubs in Israel through its subsidiaries. In Germany, it imports cannabis and sells through its own IMC branded products and exclusive ultra premium Canadian brands via its subsidiary…

Read more ↓
Sector: Consumer Staples Sector rationale The company's primary revenue is derived from the sale of cannabis products, which is explicitly listed under the Consumer Staples sector. However, because the company specifically focuses on the importation, distribution, and sale of medical cannabis to medical patients and healthcare providers, it also operates within the Healthcare sector. Industries: Cannabis Consumer Staples Primary The company's primary business is the importation, distribution, and sale of medical cannabis flower and extracts, which contributed 53,186 thousand CAD of its total revenue. It operates medical cannabis retail pharmacies and distribution centers to serve medical patients in Israel and Germany. Pharmacies Consumer Staples Secondary The company operates its own medical cannabis retail pharmacies and online platforms in Israel to sell products directly to patients. Classified using BQ-MICS CIK: 0001792030

Segment consolidation items [axis] Breakdown of Revenue (2023)

Products and services [axis] Breakdown of Revenue (2023)

Peer Comparison

Companies in the Drug Manufacturers - Specialty & Generic
S.No. Ticker Company Market CapP/EP/STotal Debt (Qtr)
1 HLN Haleon plc 86.50 Bn80.681.67-5.81 Bn
2 TEVA Teva Pharmaceutical Industries Ltd 42.71 Bn61.362.4716.59 Bn
3 ZTS Zoetis Inc. 30.86 Bn11.803.249.05 Bn
4 TAK Takeda Pharmaceutical Co Ltd 28.50 Bn49.630.6131.47 Bn
5 UTHR UNITED THERAPEUTICS Corp 22.06 Bn16.836.99-
6 VTRS Viatris Inc 18.84 Bn-45.871.2813.35 Bn
7 NBIX Neurocrine Biosciences Inc 15.55 Bn22.034.61-
8 VREOF Vireo Growth Inc. 11.86 Bn-238.0033.850.20 Bn